Atiprimod (SK and F 106615), a novel macrophage targeting agent, enhances alveolar macrophage candidacidal activity and is not immunosuppresive in candida-infected mice

International Journal of Immunopharmacology

Volumn 21, Issue 3, 1999, Pages 161-176

  Badger, Alison M ^a   Handler, Jeffrey A ^a   Genell, Caroline A ^a   Herzyk, Danuta ^a   Gore, Elizabeth ^a   Polsky, Rodd ^a   Webb, Lee ^a   Bugelski, Peter J ^a,b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; ATIPRIMOD; CATALASE; COLCHICINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; METHOTREXATE; OXYGEN RADICAL; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

ACRIDINE ORANGE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIFUNGAL AGENTS; CANDIDIASIS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLUORESCENT DYES; IMMUNOSUPPRESSIVE AGENTS; LYSOSOMES; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED CBA; RATS; RATS, INBRED LEW; SPIRO COMPOUNDS;

EID: 0033063111     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00076-9     Document Type: Article

References (41)

1. Adams, D. O., and Hamilton, T. A. (1984). The cell biology of macrophage activation. Annu. Rev. Immunol., 2, 283-318.
2. Albrightson-Winslow, C. R., Brickson, B. B., King, A., Olivera, D., Short, B., Saunders, C., and Badger, A. M. (1990). Beneficial effects of long-term treatment with SKandF 105685 in murine lupus nephritis. J. Pharmacol. Exp. Ther., 255, 382-387.
3. Badger, A. M., DiMartino, M. J., Talmadge, J. E., Picker, D. H., Schwartz, D. A., Dorman, J. W., Mirabelli, C. K., and Hanna, N. (1989). Inhibition of animal models of autoimmune disease and the induction of non-specific suppressor cells by SKandF 105685 and related azaspiranes. Int. J. Immunopharmacol., 11, 839-846.
4. Badger, A. M., Newman-Tarr, T. M., and Satterfield, J. L. (1997). Selective immunomodulatory activity of SKandF 106615, a macrophage-targeting antiarthritic compound, on antibody and cellular responses in rats and mice. Immunopharmacology, 37, 53-61.
5. Badger, A. M., Schwartz, D. A., Picker, D. H., Dorman, J. W., Bradley, F. C., Cheeseman, E. N., DiMartino, M. J., Hanna, N., and Mirabelli, C. K. (1990). Antiarthritic and suppressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents. J. Med. Chem., 33, 2963-2970.
6. Bradbeer, J. N., Kapadia, R. D., Sarkar, S. K., Zhao, H., Stroup, G. B., Swift, B. A., Rieman, D. J., and Badger, A. M. (1996). Disease-modifying activity of SKandF 106615 in rat adjuvant-induced arthritis. Arthritis. Rheum., 39, 504-514.
7. Brummer, E., and Stevens, D. A. (1989). Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or gamma-interferon. J. Med. Microbial., 28, 173-181.
8. Bugelski, P. J., Kaplan, J. M., Hart, T. K., Miller, J., Layon, J. T., Lee, J. C., Dreyer, G. B., and Kirsh, R. (1992). Effect of a human immunodeficiency virus protease inhibitor on human monocyte function. AIDS Res. Hum. Retroviruses, 8, 1951-1958.
9. Bugelski, P. J., Ruggieri, E., Polsky, R., Cunningham, L., Handler, J., Eustis, S., Kapadia, R., Sarkar, S., Schnell, M., Badger, A. M., and Herzyk, D. (1996). Therapeutic effect of SKandF 106615 on pristane-induced arthritis in mice. Arthritis Rheum., 39, S247.
10. Busch, G. L., Lang, H. L., and Lang, F. (1996). Studies on the mechanism of swelling-induced lysosomal alkalinization in vascular smooth muscle cells. Pflugers Arch, 431, 690-696.
11. Butor, C., Griffiths, G., Aronson, N. N. J., and Varki, A. (1995). Co-localization of hydrolytic enzymes with widely disparate pH optima: implications for the regulation of lysosomal pH. J. Cell Sci., 108, 2213-2219.
12. Catteral, J. R., Black, C. M., Leventhal, J. P., Rizk, N. W., Wachtel, J. S., and Remington, J. S. (1993). Nonoxidative microbicidal activity in normal human alveolar and peritoneal macrophages. Infect. Immun., 55, 1635-1640.
13. Cenci, E., Romani, L., Mancacci, A., Spaccapelo, R., Schiaffella, I., Puccetti, P., and Bistoni, F. (1993). Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur. J. Immunol., 23, 1034-1038.
14. Fan, P. Y., Albrightson-Winslow, C. R., Howell, D., Best, C., Badger, A. M., and Coffman, T. M. (1993). The azaspirane SKandF 105685 ameliorates renal allograft rejection in rats. J. Am. Soc. Nephrol., 3, 1680-1685.
15. Guentzel, M. N., and Herrera, C. (1982). Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy. Infect Immun., 35, 222-228.
16. Hancock, W. W., Schmidbauer, G., Badger, A. M., and Kupiec-Weglinski, J. W. (1992). SKandF 105685 suppresses allogeneically induced mononuclear endothelial cell activation and cytokine production, and prolongs rat cardiac allograft survival. Transplant Proc., 24, 231-232.
17. Hart, P. D. (1981). Macrophage antimicrobial activity: evidence for participation by lysosomes in the killing of Saccharomyces cerevisiae by normal resident macrophages. Infect. Immun., 31, 828-830.
18. Haveman, J. (1980). The capacity of lysosomes of cultured mammalian cells to accumulate acridine orange is destroyed by hyperthermia. J. Cell. Tissue Res., 213, 343-350.
19. Herzyk, D. J., Ruggieri, E. V., Cunningham, L., Polsky, R., Herold, C., Klinkner, A., Badger, A. M., Kerns, W. D., and Bugelski, P. J. (1997). Single-organism model of host defense against infection: a novel immunotoxicologic approach to evaluate immunomodulatory drugs. Tox. Path., 25, 351-362.
20. High, W. B., Bugelski, P. J., Nichols, M. E., Swift, B. A., Solleveld, H. A., and Badger, A. M. (1994). Effects of a novel azaspirane (SKandF 105685) on the arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrity. J. Rheumatol., 150, 17A.
21. Hurley, D. L., and Balow, J. E. (1975). Experimental disseminated candidiasis. 2. Administration of glucocorticosteroids, susceptibility to infection and immunity. J. Infect. Dis., 132, 393-398.
22. Jeong, J. Y. (1997). Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages. J. Immunol., 158, 4901-4907.
23. Kamble, A. B., and Mellors, A. (1975). Effects of ten steroids on acridine orange uptake and beta-N-acetylglucosaminidase levels in rat liver lysosomes. Steroids, 25, 441-455.
24. Khraishi, M. M., and Singh, G. (1996). The role of anti-malarials in rheumatoid arthritis - the American experience. LUPUS, 1, S41-S44.
25. Kodavanti, U. P., and Mehendale, H. M. (1990). Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacol. Rev., 42, 327-354.
26. Krause, M. W., and Shaffner, A. (1989). Comparison of immunosuppressive effects of cyclosporine A in a murine model of systemic candidiasis and of localized thrushlike lesions. Infect. Immun., 57, 3472-3478.
27. Levitz, S. M., Harrison, T. S., Tabuni, A., and Liu, X. (1997). Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation. J. Clin. Invest., 100, 1640-1646.
28. MacIntyre, A., C., and Cutler, D. J. (1993). Kinetics of chloroquine uptake into isolated rat hepatocytes. J. Pharmaceut. Sci., 82, 592-600.
29. Marodi, L., Forehand, J. R., and Johnston, R. B. J. (1991). Mechanisms of host defense against Candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes. J. Immunol., 146, 2790-2794.
30. Pasero, G. (1997). The treatment of rheumatoid arthritis in this century: from spas to monoclonal antibodies. Clin. Exp. Rheumatol., 17, S67-S70.
31. Pick, E., and Mizel, D. J. (1981). Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J. Immunol. Meth., 46, 211-226.
32. Poole, B., and Ohkuma, S. (1981). Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. Cell Biol., 90, 665-669.
33. Rabinovitch, A., Suarez, W. L., Qin, H. Y., Power, R. F., and Badger, A. M. (1993). Prevention of diabetes and induction of non-specific suppressor cell activity in the BB rat by an immunomodulating azaspirane, SKandF 106610. J. Autoimmun., 1, 39-49.
34. Redmond, J. P., Shou, J., Gallagher, H. J., Kelly, C. J., and Daly, J. M. (1993). Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms. J. Immunol., 150, 3427-3433.
35. Sasada, M., and Johnston, R. B. J. (1980). Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J. Exp. Med., 152, 85-98.
36. Schmidbauer, G., Hancock, W. W., Badger, A. M., and Kupiec-Weglinski, J. W. (1993). SKandF 105685, a novel immunoregulatory azaspirane induces non-specific X-irradiation resistant suppressor cell activity in vivo and prolongs vascularized allograft survival. Transplantation, 55, 1236-1243.
37. Shimokawa, O., and Nakayama, H. (1992). Increased sensitivity of Candida albicans cells accumulating 14 alpha-methylated sterols to active oxygen: possible relevance to in vivo efficacies of azole antifungal agents. Antimicrob. Agents Chemother., 36, 1626-1629.
38. Steck, T. L., Kezdy, F. J., and Lange, Y. (1988). An activation-collision mechanism for cholesterol transfer between membranes. J. Biol. Chem., 263, 13,023-13,031.
39. Thorne, K. J., Ovier, R. C., and Barrett, A. J. (1976). Lysis and killing of bacteria by lysosomal proteinases. Infect. Immun., 14, 555-563.
40. Thurman, R. G., and Kauffman, F. C. (1979). Factors regulating drug metabolism in intact hepatocytes. Pharmacol. Rev., 31, 229-251.
41. Waites, C. R., Bugelski, P. J., and Badger, A. M. (1995). Biochemical and functional analysis of rat bronochoalveolar macrophages containing chemically induced phospholipid inclusions. Toxicol-Appl-Pharmacol., 130, 316-321.